Threshold power levels for NPe6 photodynamic therapy

Area of Science:

• Ophthalmology
• Photodynamic Therapy
• Vascular Biology

Background:

• Photodynamic therapy (PDT) utilizes photosensitizers and light to create cytotoxic effects.
• Mono-L-aspartyl chlorin e6 (NPe6) is a photosensitizer used in PDT.
• Vascular occlusion is a potential complication of PDT.

Purpose of the Study:

• Determine threshold power levels for NPe6-induced retinal and choroidal vascular occlusion.
• Evaluate PDT efficacy with varied intervals between NPe6 injection and laser application.
• Ascertain the time course of angiographic changes post-laser treatment.

Main Methods:

• Intravenous injection of NPe6 (2 mg/kg) in rabbits followed by laser irradiation.
• Assessment of lesion formation and diameter at varying power levels (fluence).
• Fluorescein angiography used to evaluate vascular occlusion and time course.

Main Results:

• Choroidal vessel occlusion observed at fluences as low as 0.88 J/cm² (nonpigmented) and 2.65 J/cm² (pigmented) rabbits.
• Lesion size decreased with longer intervals between NPe6 injection and laser treatment.
• Vascular occlusion was evident at least 2 hours after laser application.

Conclusions:

• Choroidal vascular occlusion is achievable with NPe6 PDT at very low fluences.
• Timing of laser application relative to NPe6 injection influences treatment outcome.
• Angiographic evidence of occlusion can be delayed up to 2 hours post-treatment.